{"name":"PaxVax","permalink":"paxvax","crunchbase_url":"http://www.crunchbase.com/company/paxvax","homepage_url":"http://paxvax.com/","blog_url":"","blog_feed_url":"","twitter_username":"","category_code":"biotech","number_of_employees":null,"founded_year":2007,"founded_month":null,"founded_day":null,"deadpooled_year":null,"deadpooled_month":null,"deadpooled_day":null,"deadpooled_url":null,"tag_list":"","alias_list":"","email_address":"hr@paxvax.com","phone_number":"(858) 450-9595","description":"Infectious Disease Oral Vaccines","created_at":"Mon Nov 09 23:37:58 UTC 2009","updated_at":"Mon Mar 26 01:01:56 UTC 2012","overview":"<p>PaxVax is a vaccine start-up company developing candidate oral vaccines for influenza, and key infectious diseases.</p>\n\n<p>PaxVax has developed a proprietary oral vaccine technology based on a common virus called adenovirus. The technology removes the delivery hurdles of traditional injectable vaccines, namely the need for cold storage, needles, and administration by medical personnel.</p>\n\n<p>PaxVax has raised more than $50 million from investors including Ignition Partners and the Wellcome Trust, and is supported by grants from the U.S. National Institutes of\nHealth (NIH) through the National Institute of Allergy and Infectious Diseases (NIAID) and its Division of Acquired Immunodeficiency Syndrome (DAIDS), as well as the Bill and Melinda Gates Foundation.</p>","image":{"available_sizes":[[[150,60],"assets/images/resized/0006/5571/65571v1-max-150x150.png"],[[198,80],"assets/images/resized/0006/5571/65571v1-max-250x250.png"],[[198,80],"assets/images/resized/0006/5571/65571v1-max-450x450.png"]],"attribution":null},"products":[],"relationships":[{"is_past":false,"title":"Executive Chairman, CEO","person":{"first_name":"Kenneth","last_name":"Kelley","permalink":"kenneth-kelley","image":null}},{"is_past":false,"title":"CSO","person":{"first_name":"Jonathan","last_name":"F. Smith","permalink":"jonathan-f-smith","image":null}},{"is_past":false,"title":"CFO","person":{"first_name":"Janine","last_name":"Taylor","permalink":"janine-taylor","image":null}},{"is_past":false,"title":"CMO","person":{"first_name":"Marc","last_name":"Gurwith","permalink":"marc-gurwith","image":null}},{"is_past":false,"title":"EVP & COO","person":{"first_name":"Nima","last_name":"Farzan","permalink":"nima-farzan","image":null}},{"is_past":false,"title":"VP Project Management","person":{"first_name":"Deborah","last_name":"Mosca","permalink":"deborah-mosca","image":null}},{"is_past":false,"title":"VP Operations","person":{"first_name":"Paul","last_name":"Shabram","permalink":"paul-shabram","image":null}},{"is_past":false,"title":"CTO","person":{"first_name":"Thomas","last_name":"P. Monath","permalink":"thomas-p-monath","image":null}}],"competitions":[],"providerships":[],"total_money_raised":"$2M","funding_rounds":[{"round_code":"unattributed","source_url":"http://www.xconomy.com/san-diego/2009/11/09/san-diegoâ€™s-paxvax-developing-oral-tablet-vaccine-looks-to-raise-more-cash-with-support-of-seattles-ignition-capital/","source_description":"Xconomy San Diego","raised_amount":2000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":11,"funded_day":9,"investments":[{"company":null,"financial_org":{"name":"Ignition Partners","permalink":"ignition-partners","image":{"available_sizes":[[[150,59],"assets/images/resized/0001/9291/19291v1-max-150x150.png"],[[156,62],"assets/images/resized/0001/9291/19291v1-max-250x250.png"],[[156,62],"assets/images/resized/0001/9291/19291v1-max-450x450.png"]],"attribution":null}},"person":null}]}],"investments":[],"acquisition":null,"acquisitions":[],"offices":[{"description":"San Diego Office","address1":"3985A Sorrento Valley Boulevard","address2":"","zip_code":"92121","city":"San Diego","state_code":"CA","country_code":"USA","latitude":null,"longitude":null},{"description":"Menlo Park Office","address1":"1010 El Camino Real, STe 380","address2":"","zip_code":"94025","city":"Menlo Park","state_code":"CA","country_code":"USA","latitude":null,"longitude":null}],"milestones":[{"description":"FDA accepts IND for single-dose oral cholera vaccine","stoned_year":2012,"stoned_month":3,"stoned_day":19,"source_url":"http://paxvax.com/wp-content/uploads/PaxVax_Cholera_IND_0319121.pdf","source_text":null,"source_description":"FDA Accepts PaxVax’s IND for Single-Dose Oral Cholera Vaccine","stoneable_type":"Company","stoned_value":null,"stoned_value_type":null,"stoned_acquirer":null,"stoneable":{"name":"PaxVax","permalink":"paxvax"}}],"ipo":null,"video_embeds":[],"screenshots":[],"external_links":[]}